Actively Recruiting
Combined Effects of INF and OEP in Patients With Diabetic Peripheral Neuropathy
Led by Riphah International University · Updated on 2025-12-10
65
Participants Needed
1
Research Sites
65 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
DPN often leads to balance issues, sensory deficits, and chronic pain, which can severely impact daily functioning and independence. INF therapy aims to improve nerve blood flow and alleviate neuropathic symptoms through manual techniques, while the Otago Exercise Program focuses on enhancing strength and balance to reduce fall risk. By comparing these two interventions, this study seeks to identify effective strategies that can improve balance, reduce pain, and enhance the quality of life for individuals suffering from DPN
CONDITIONS
Official Title
Combined Effects of INF and OEP in Patients With Diabetic Peripheral Neuropathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 50 to 75 years
- Male and female patients
- Diagnosed with type 2 diabetes mellitus
- DN4 neuropathic pain score of 4 or higher
- Timed Up-and-Go (TUG) test score less than 15 seconds
- Able to walk at least 10 meters
You will not qualify if you...
- Presence of systemic diseases other than diabetes (e.g., end-stage renal failure, uncontrolled hypertension, severe dyslipidemia, chronic liver disease, autoimmune disease, advanced COPD)
- Documented active alcohol or drug misuse
- Total or partial lower extremity amputation
- Morbid obesity or pregnancy (self-reported)
- Active inflammation or inflammatory neuropathies including chronic inflammatory demyelinating polyneuropathy, proximal diabetic neuropathy, chemotherapy-induced peripheral neuropathy, autonomic neuropathies, or neuropathies not related to diabetes such as B12 deficiency
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rasheed Hospital
Lahore, Punjab Province, Pakistan, 54800
Actively Recruiting
Research Team
I
Imran Amjad, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here